Let me mention some market buzz in the pharma sector. “Mint” a business newspaper published from India in collaboration with the Wall Street Journal reports that GlaxoSmithKline Plc, Sanofi Aventis and Merck are all wanting to expand and make investments. Does this not demonstrate that business prospects exist even in the bear market and there are ways to expand and beat the downturn? Of course the challenges of entering into new markets is always there and you will need to do due diligence, identify the opportunity, prepare a business plan, require hand holding support, resource the new organization etc. etc.
The above example is not a case of outsourcing of jobs, it is a case of expanding business footprint through synergy and collaboration.
Tomorrow I will dwell a bit on the opportunities in the clinical research area.

Related Posts:

Pin It on Pinterest

Shares